Ionis Pharmaceuticals, Inc. (IONS) Free cash flow 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$320.0MFY2025 · since FY2016: -$119.2M → -$320.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$320.0M | +41.4% |
| FY2024 | -$546.2M | -64.9% |
| FY2023 | -$331.3M | -14.2% |
| FY2022 | -$290.1M | -1639.4% |
| FY2021 | $18.8M | +2340.9% |
| FY2020 | $772,000 | -99.8% |
| FY2019 | $314.7M | -46.6% |
| FY2018 | $589.3M | +322.8% |
| FY2017 | $139.4M | +216.9% |
| FY2016 | -$119.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IONS financial trends
IONS RevenueIONS Net incomeIONS Net marginIONS Gross profitIONS Gross marginIONS Operating incomeIONS Operating marginIONS Operating cash flowIONS Capital expendituresIONS Return on equityIONS Stock buybacksIONS Dividends paidIONS Total assetsIONS Total liabilitiesIONS Shareholders’ equityIONS overview →